Research to Reality: Transformation in Life Sciences
Date: May 16th & May 17th
Live Event: 9:00 AM – 12:00 PM EDT
Replay: 9:00 PM – 12 AM EDT
Agenda
Tuesday, May 16th 2023 | |||
|---|---|---|---|
Masters of Ceremony: Anna Marie Detert, Partner, Healthcare and Life Sciences, KPMG UK Guillaume Favier, Strategy Partner, Healthcare and Life Sciences, KPMG UK | |||
| Time | Session | Speaker(s) | KPMG Host |
9:00 am – 9:55 am | Session 1: Industry and Economic Outlook | ||
1A: Healthcare Outlook | Anna van Poucke, Global Head of Healthcare at KPMG International | ||
1B: Economic Outlook | Yael Selfin, Chief Economist, KPMG UK | ||
| 1C: Digital Healthcare Solutions | Dr. Alexander Condoleon, Vice President, Head of Digital Healthcare, Sanofi | Alison Little, Principal, Advisory KPMG US | |
10:00 – 10:55 a.m. | Session 2: Deals, M & A, Alliances | ||
| 2A: Connectivity, Trust, Collaboration – a new way for partnerships | Jean-Christophe Tellier, CEO at UCB
|
Kristin Pothier, Global Life Sciences Deal Advisory and Strategy Leader, KPMG US
|
| 2B: FTC Antitrust Battle with Facebook and the impact on future deals in Life Sciences | Arman Oruc, Partner at Goodwin, Co-Chair, Anti-Trust, Goodwin | Jeff Stoll, PhD, Partner, National Leader Life Sciences, Strategy Consulting, KPMG US
|
11:00 - 11:55 a.m. | Session 3: Advancing ESG Solutions: Initiatives to Support the Health of People and Planet | ||
| 3A: Women in Technology | Michelle Greene, Executive Vice President and Chief Information Officer, Cardinal Health | Fiona Thomas, Chief Medical Officer, KPMG UK |
| 3B: Women’s Health Innovation | Dr. Sandy Milligan, Head of Research and Development, Organon | Fiona Thomas, Chief Medical Officer, KPMG UK |
| 3C: Responsible Sourcing | Kevin Nelson, SVP & CPO, Becton Dickinson | Blythe Chorn, Managing Director, Consulting, ESG Leader, KPMG US |
| 3D: Health Equity | Rady Johnson, Chief Compliance, Quality & Risk Officer, Pfizer, Inc. | Melissa Taylor, Partner, Audit, KPMG US | |
Wednesday, May 17th 2023 | |||
|---|---|---|---|
| Time | Session | Speaker(s) | KPMG Host |
9:00 am – 9:55 am | Session 4: Data Science and Technology | ||
4A: Data as an asset: Explore how creating a data asset enables competitive differentiation and strategic advantage | Rachel Lin, Regional Commercial Director, Janssen Asia Pacific Freddie Yi Yu, Director & Data Scientist, Janssen Asia Pacific Thomas Halliday, LifeScience & Healthcare, Customer Vertical Leader, Clarivate | Anastasia Miros, Director, Healthcare and Life Sciences, KPMG Asia Pacific | |
4B: Customer and employee digital transformation | Hank Yang, Managing Director, Healthcare and Life Sciences, KPMG US Roni Kopelman, Managing Director, Human Capital Advisory, KPMG US | ||
| 4C: Avalon: The world's first healthcare metaverse | Shafi Ahmed, Chief Medical Officer, Medical Realities | Justin Hoss, Principal Advisory, KPMG US | |
10:00 – 10:55 a.m. | Session 5: Connected Enterprise | ||
| 5A: Data privacy | Brian Cincera, SVP & Chief Information Security Officer, Pfizer, Inc. | Caroline Rivett, Cyber in Life Sciences Global Lead, KPMG, UK |
5B: Innovation in Compliance | John Gitas, Principal, Advisory, Forensic, KPMG US Matthew Colford, Director, Healthcare and Life Sciences Advisory, KPMG US | ||
| 5C: Patient Safety and Quality | Steve C de Baca, Chief Patient Safety and Quality Officer, Philips | Rajesh Misra, Principal, Life Sciences Operations Advisory, KPMG US | |
11:00 am – 11:55 am | Session 6: Future of Life Sciences | ||
| 6A: Roadblocks on the path to Precision Medicine | Luca Dezzani, VP US Oncology Medical Affairs, Johnson & Johnson | Alasdair Milton, Managing Director, Healthcare & Life Sciences, KPMG US |
| 6B: The role of the patient in the evolving patient journey of Precision Medicine in Neurodegenerative Diseases | Pearl Pugh, President, Neuroscience, Johnson & Johnson Dr. Howard Fillit, Co-Founder and Chief Science Officer at the Alzheimer's Drug Discovery Foundation | Varun Renjen, MD Managing Director, Life Sciences Deal Advisory and Strategy, KPMG US |
